BioCentury
ARTICLE | Clinical News

BreathID: Pivotal trial started

November 24, 2014 8:00 AM UTC

Exalenz began an international pivotal trial to compare BreathID vs. the use of HVPG in at least 200 patients with chronic liver disease. ...